You have searched for "Vials"
Showing 1-10 of 532
GENEVA (Reuters) - The world cannot act soon enough to put idle manufacturing capacity to work making COVID-19 vaccines to help redress a massive imbalance in global supply, the head of the World Trade Organization said on Wednesday.
WASHINGTON (Reuters) - World Bank President David Malpass on Wednesday urged wealthy countries to quickly free up excess vaccines for developing economies that are now facing greater needs, by exporting stockpiled doses and giving up options for future deliveries.
NEW DELHI (Reuters) -A top scientific adviser to the Indian government warned on Wednesday the country would inevitably face further waves of the coronavirus pandemic, as almost 4,000 people died in the space of a day.
PUTRAJAYA (Bernama): The Health Ministry will constantly monitor the incidence of blood clots with the administration of the AstraZeneca Covid-19 vaccine and will give immediate treatment if such an event occurs, says Health Minister Datuk Seri Dr Adham Baba.
BRUSSELS (Reuters) - Novavax has told the European Union it plans to begin delivering its COVID-19 vaccine to the bloc towards the end of this year, new guidance that could lead to a formal contract being signed as early as this week, an EU official told Reuters.
PETALING JAYA: Some Malaysians are ensuring they are well-prepared ahead of the Covid-19 AztraZeneca vaccine registration on Sunday (May 2) and have set up contingency plans in the event of server glitches, lags, or website crashes due to a predicted rush of signups.
The World Health Organisation (WHO) on Saturday has listed the Moderna COVID-19 vaccine for emergency use, making it the fifth vaccine to receive emergency validation from the WHO.
(Reuters) - American depositary shares of Vaccitech, which co-invented the COVID-19 vaccine developed by AstraZeneca Plc and Oxford University, fell nearly 20% in their market debut on Friday, giving the biotech firm a market value of about $464 million.
LONDON (Reuters) - AstraZeneca is working as fast as possible to compile data on its COVID-19 vaccine to apply for U.S. approval but the dataset is very big, executives said on Friday as the drugmaker faces delays to its submission.